GlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...

GlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and oncology in Indi...

Research firm PharmaTrac data shows Augmentin sales at Rs 801 crore from November 2022-23. For the month of November, Augmentin sales stood...

Our Q2 performance reflects an overall recovery with market share gains in several key promoted brands across all business units. We held l...

Despite the strong external headwinds, GSK remains focused on delivering best-in-class competitive performance and driving operational effi...

GlaxoSmithKline Pharmaceuticals (GSK India) on Wednesday reported 13% year-on-year (YoY) jump of net profit to Rs 131 crore for the quarter...

GSK India reported a net profit of Rs 133 crore for the quarter ended March 31, 2023, with continued momentum across general medicines and ...

The adult vaccine recommended for people aged 50 years and above, provides protection against shingles - a disease associated with debilita...

Before joining GSK, Akshikar spent 15 years with Janssen, Johnson & Johnson in various roles leading both specialty and primary care busine...

Akshikar with over 26 years experience within the pharmaceutical industry, joined GSK India in September 2011 to lead the specialty and com...